Forging New Therapeutics for the Management of Inflammation
Galileo Biosystems, Inc. is a preclinical stage biopharmaceutical company advancing a portfolio of novel and mechanistically differentiated therapeutic aryl hydrocarbon receptor modulating agents (TAMA) for the treatment of inflammatory and autoimmune diseases.
Who We Are
At Galileo, we are committed to providing innovative treatment solutions for inflammatory conditions and rare diseases. Our team of experts have developed novel treatments that tackle the complexities of the immune system and are designed to bring relief to people living with hard-to-treat conditions.
We combine cutting-edge technology and the latest scientific knowledge to create solutions that are tailored to the individual needs of each patient. Our team is dedicated to helping people live healthier and happier lives.
